Recent Non-Surgical Advances in Management of Presbyopia

Abstract

Presbyopia is an age-related decrease in the eye’s ability to focus on near objects, affecting nearly all individuals over 40 years of age. Increasing life expectancy and greater dependence on digital devices have increased their impact on quality of life. Recent non-surgical advances include improved multifocal optical correction and pharmacological therapies, such as pilocarpine and aceclidine-based eye drops, which enhance near vision by increasing the depth of focus. Emerging lens-softening therapies aimed at restoring accommodation are currently being investigated. However, no current treatment fully restores natural accommodation with long-term safety and efficacy. Future therapies are expected to focus on personalised, restorative treatment approaches to improve vision and quality of life in patients with presbyopia.
This review focuses on contemporary non-surgical approaches to presbyopia, highlighting recent developments in pharmacological eye-drop therapy and important considerations for patient selection and treatment initiation.